Author (date) | Patients with RA/controls | Test for anti-CCP2 | Sensitivity (%) | Specificity (%) |
---|---|---|---|---|
ED, Euro-Diagnostica; AS, Axis-Shield. | ||||
Dubucquoi (2004)33 | 46/22 | ED | 85 | 91 |
AS | 82 | 91 | ||
INOVA | 85 | 95.5 | ||
Garcia-Berrocal (2005)22 | 87/46 | ED | 74 | 85 |
AS | 43 | 85 | ||
INOVA | 77 | 85 | ||
Fernandez-Suarez (2005)12 | 53/75 | ED | 52.8 | 100 |
AS | 52.8 | 100 | ||
INOVA | 58.5 | 100 | ||
Greiner (2005)16 | 87/246 | ED | 81 | 98 |
INOVA | 80 | 97 | ||
EUROIMMUN | 81 | 98 |